comparemela.com

Page 4 - Slrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Driehaus Capital Management LLC Makes New Investment in Acelyrin, Inc (NASDAQ:SLRN)

Driehaus Capital Management LLC acquired a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the second quarter, HoldingsChannel.com reports. The institutional investor acquired 1,758,797 shares of the company’s stock, valued at approximately $36,759,000. A number of other hedge funds and other institutional investors have also bought and sold shares of the […]

Driehaus Capital Management LLC Buys New Position in Acelyrin, Inc (NASDAQ:SLRN)

Driehaus Capital Management LLC bought a new stake in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,758,797 shares of the company’s stock, valued at approximately $36,759,000. Driehaus Capital Management LLC owned about 1.81% of […]

CHI Advisors LLC Makes New Investment in Acelyrin, Inc (NASDAQ:SLRN)

CHI Advisors LLC bought a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin makes up 16.8% of CHI Advisors LLC’s holdings, making the stock its 2nd biggest holding. Other hedge funds […]

CHI Advisors LLC Acquires New Shares in Acelyrin, Inc (NASDAQ:SLRN)

CHI Advisors LLC acquired a new stake in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin comprises approximately 16.8% of CHI Advisors LLC’s […]

HC Wainwright Reaffirms Buy Rating for Acelyrin (NASDAQ:SLRN)

HC Wainwright restated their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $30.00 target price on the stock. Separately, Morgan Stanley lowered Acelyrin from an overweight rating to an equal weight rating and dropped their target price for the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.